Get a Quote
Receive a tailored pricing based on your needs.
- Choose license type
- Multiple user options
- Custom scope & coverage
- Fast turnaround
"Designing Growth Strategies is in our DNA"
The pediatric catheters market size was valued at USD 9.76 Billion in 2025. The market is projected to grow from USD 10.68 Billion in 2026 to USD 21.98 Billion by 2034, exhibiting a CAGR of 9.45% during the forecast period.
The pediatric catheters market is an essential segment within the broader medical devices industry, focusing on small‑sized catheter devices designed specifically for infants, children, and adolescents whose physiological demands differ significantly from adults. Pediatric catheters are used in a range of clinical procedures including cardiovascular diagnostics, urology treatments, neonatal intensive care interventions, neurovascular treatments, and specialty applications requiring precision access to small vessels or organ systems. The pediatric catheters market Report highlights increasing healthcare investments, technological innovation in catheter materials and features, and growing awareness of pediatric surgical care as core elements shaping this sector’s development. As healthcare providers prioritize patient safety and procedural outcomes, pediatric catheter technologies continue to evolve with infection prevention, flexibility, and secure placement mechanisms front of mind.
In the USA pediatric catheters market, advanced healthcare infrastructure, extensive hospital networks, and heightened clinical focus on neonatal and pediatric care drive demand for specialized catheters. The USA market is characterized by high adoption of minimally invasive procedural protocols, strong regulatory standards for pediatric medical devices, and significant efforts by healthcare institutions to improve pediatric outcomes. Federal initiatives, hospital level quality improvement programs, and robust reimbursement frameworks enhance purchasing of pediatric catheters by children’s hospitals, NICUs (Neonatal Intensive Care Units), and tertiary medical centers. Access to pediatric catheter technologies, including those with antimicrobial coatings and ultrasound‑guided features, remains a priority for caregivers and procurement teams aiming to reduce complications and optimize care pathways.
North America
North America held the largest regional market share at 34% in 2025.
Europe
Europe accounted for 28% of the global market.
Asia-Pacific
Asia-Pacific represented 26% of the global market.
U.S.
The U.S. market is supported by rising pediatric healthcare needs and increasing demand for specialized catheter-based procedures.
Japan
The Japan market is supported by advancements in pediatric medical care and growing adoption of minimally invasive catheter-based procedures.
Read More
The pediatric catheters market trends reflect a dynamic shift toward precision, safety, and outcomes‑driven innovation. One of the notable trends in the pediatric catheters market analysis is the design and adoption of catheters with antimicrobial and antithrombotic surface treatments that reduce infection rates and clot formation, which is particularly crucial in neonatal and pediatric cardiac interventions. Healthcare providers are increasingly selecting catheter products that integrate advanced materials such as flexible polyurethane and soft silicone to improve biocompatibility and reduce trauma. These trends are driven by clinical evidence showing better outcomes and fewer complications in delicate pediatric vascular systems.
Download Free sample to learn more about this report.
Another key trend in the pediatric catheters market Insights is image‑guided vascular access and tip placement technologies. Innovations such as integrated imaging guidance and real‑time confirmation tools reduce first‑attempt failure rates and procedural times, which is especially important in pediatric intensive care units. Additionally, the Pediatric Catheters industry Report highlights a shift toward single‑use catheter solutions, improving infection control and aligning with hospital safety protocols.
The pediatric catheters market outlook also includes the integration of digital technologies for securement systems and telemetry, allowing clinicians to monitor positioning and function post‑placement. As pediatrics continues to embrace minimally invasive surgical standards, catheter developers are aligning product portfolios with clinician preferences for products that deliver precision, safety, and workflow efficiency.
Rising Incidence of Congenital and Pediatric Disorders Requiring Catheter Interventions.
The pediatric catheters market growth is strongly influenced by the increasing incidence of congenital heart defects, pediatric urological conditions, neurologic abnormalities, and the growing global pediatric population requiring specialized care. Catheters are crucial in diagnostic procedures, surgical treatments, medication delivery, and long‑term vascular support in neonatal and pediatric care units. As congenital heart disease detection improves and survival rates of premature infants increase due to advanced neonatal care, the need for precise catheter access for interventional cardiology and critical care escalates. These factors, combined with hospital modernization efforts and expanding healthcare coverage, boost demand for pediatric catheter devices globally.
Moreover, clinical protocols increasingly favor minimally invasive surgical techniques to reduce risk, hospital stays, and recovery times, translating into higher utilization of specialized catheters. Hospitals and pediatric specialty centers are investing in catheter technologies that reduce insertion complications, integrate real‑time guidance, and offer size‑optimized options for neonates through adolescents, making them indispensable in contemporary pediatric practice. The pediatric catheters market Forecast underscores this trend, with product innovation and widespread clinical adoption reinforcing long‑term market expansion.
High Costs and Reimbursement Challenges in Pediatric Catheter Procurement.
One of the significant Pediatrics Catheters Market Restraints stems from the high cost associated with pediatric‑specific catheter technologies compared to standard adult products. Advanced material formulations, coatings that prevent infection or thrombosis, and integrated guidance systems elevate manufacturing complexity and price points. While hospitals recognize the clinical advantages of such innovations, emerging markets may struggle with reimbursement limitations, budget constraints, or lack of dedicated pediatric device procurement funds. This pricing pressure can influence purchasing decisions and slow the replacement of legacy products or technologies that do not meet the latest safety standards.
Additionally, inconsistent reimbursement frameworks across regions can lead to variability in adoption. Some healthcare systems do not differentiate pediatric device fees sufficiently, which discourages widescale adoption of premium catheter technologies. In countries lacking comprehensive pediatric care financing, cost barriers may limit clinical access, especially in outpatient settings or smaller regional hospitals. These restraints necessitate strategic planning by manufacturers to balance innovation with cost‑effective delivery models that align with diverse healthcare budgets.
Expansion of Pediatric Healthcare Infrastructure and Emerging Market Penetration.
Significant pediatric catheters market Opportunities exist within emerging economies where pediatric healthcare infrastructure is rapidly expanding. Governments and private health systems in Asia‑Pacific, Latin America, and parts of the Middle East are increasingly dedicating resources to neonatal care units, pediatric cardiac centers, and specialized pediatric surgery facilities. This expansion creates opportunities for catheter suppliers to introduce high‑performance products tailored to local clinical needs and safety standards.
Manufacturers can also capitalize on strategic collaborations and partnerships with regional distributors, training programs for clinicians, and hospital bundle procurement strategies that emphasize improved outcomes. As pediatric nutrition, diagnostics, and vascular access technologies evolve, integrating catheter solutions with broader pediatric care platforms increases the value proposition for healthcare systems. Innovations in telehealth support and catheter‑related procedural analytics further broaden revenue streams and market engagement opportunities for forward‑looking companies.
Managing Catheter‑Associated Complications and Clinician Training Gaps.
Despite technological strides, the pediatric catheters market Challenges include managing catheter‑associated bloodstream infections, thrombosis, and procedural placement failures which remain clinical concerns. Pediatric patients, due to their small anatomy and physiological differences, require meticulous placement and maintenance protocols. Lack of standardized training and variation in technique proficiency across care settings can increase complication rates, deterring some clinicians from adopting newer catheter technologies despite their safety claims.
Furthermore, differences in clinical practice patterns among pediatric care units emphasize the need for consistent evidence‑based protocols that clearly demonstrate improvements in outcomes attributable to advanced catheter designs. Addressing these challenges requires concerted efforts in clinician education, industry‑led training initiatives, and robust clinical data that validate performance benefits. Investments in simulation‑based training and supportive procedural platforms could bridge the proficiency divide and accelerate adoption of pediatric catheter innovations.
Cardiovascular catheters are a cornerstone segment in the pediatric catheters market Report, supporting a broad range of diagnostic and interventional procedures for congenital heart disorders and valvular anomalies in children. These devices enable clinicians to perform angiography, hemodynamic assessments, balloon angioplasty, and other catheter‑based cardiac interventions with the precision necessary for pediatric anatomy. In 2024, cardiovascular catheters accounted for the largest portion of product demand globally, representing approximately 42% of total market share due to the high prevalence of congenital cardiac conditions and the procedural need for detailed intracardiac access.
Manufacturers focus heavily on developing features that improve navigability and reduce procedural time while minimizing vascular trauma. Pediatric cardiovascular catheters come in a variety of configurations, including diagnostic guide catheters, balloon catheters, and pressure‑sensing types. Their use is especially prominent in tertiary care children’s heart centers and cardiology departments where advanced interventional protocols are standard of care. Because adolescent and neonatal cardiovascular interventions often occur in high‑intensity surgical environments, these catheters are engineered to withstand multiple device exchanges and provide reliable performance across complex vascular pathways. The robust demand for cardiovascular catheters underscores their importance in determining overall pediatric catheters market size and correlates with increased detection and treatment rates of pediatric heart disease.
Urology catheters form a significant segment of the pediatric catheters market, driven by the rising incidence of pediatric urinary tract infections (UTIs), vesicoureteral reflux, bladder dysfunction, and other renal or urethral conditions. Pediatric urology catheters accounted for approximately 38% of current market share, reflecting strong utilization in clinical urology procedures, postoperative management, and long‑term urinary drainage in infants and children.
These catheters are uniquely designed with size‑specific features that match the anatomical contours of pediatric urinary tracts, reducing irritation and promoting comfort. Various designs, including Foley, nephrostomy, and intermittent catheters, are used across surgical and ambulatory care settings. In neonatal and pediatric intensive care units, urology catheters are essential for monitoring urine output, managing obstructive conditions, and supporting recovery following reconstructive urological surgery.
Manufacturers emphasize biocompatibility, flexibility, and smooth surface finishes to minimize mucosal irritation and risk of infection. This segment’s share is also bolstered by clinical guidelines that prioritize appropriate catheter selection based on patient age and condition severity. Because of these clinical and design factors, urology catheters remain a major contributor to global pediatric catheters market growth and reflect ongoing investments in pediatric renal care.
Intravenous (IV) catheters represent another core product category in the pediatric catheters market. These devices are universally utilized across pediatric healthcare settings to enable fluid administration, medication delivery, parenteral nutrition, and hemodynamic monitoring. In 2025 estimates, IV catheters accounted for around 28% of global market share, reflecting broad clinical demand across neonatal, pediatric, and adolescent care units.
IV catheters in pediatric applications include peripheral IV catheters, central venous catheters (CVC), peripherally inserted central catheters (PICC), and specialized umbilical catheters for neonates. Their widespread use is attributed to the necessity of vascular access in emergency medicine, critical care, surgical procedures, and long‑term infusion therapies. Manufacturers are prioritizing innovations that enhance kink resistance, biocompatibility, and securement mechanisms to prevent accidental dislodgement and reduce infection complications.
Because pediatric patients have smaller and more delicate vasculature, product design emphasizes atraumatic insertion and stability. This translates into specialized sizing options, ergonomic hub configurations, and materials that balance flexibility with durability. Given their essential role in everyday pediatric care, IV catheters stand as a key segment captured within the pediatric catheters market Research Report and continue to reflect sustained demand across all healthcare tiers.
Neurovascular catheters are used in specialized interventions for pediatric patients with cerebral vascular abnormalities, aneurysms, stroke, or other neurovascular conditions requiring catheter‑based navigation. Although this segment is smaller compared to cardiovascular and urology segments, neurovascular catheters contribute significantly to the advanced therapeutic and diagnostic scope of the pediatric catheters market.
These catheters are engineered to deliver microcatheters, balloon‑assisted devices, and guide components that support delicate intracranial navigation. Pediatric neurovascular care demands extremely precise control and soft‑tipped designs to avoid injury to developing cerebral vessels. The neurovascular catheter segment’s importance emerges from increasing clinical interest in minimally invasive interventions for pediatric stroke, arteriovenous malformations, and traumatic cerebrovascular injuries. Because neurovascular conditions in children can be life threatening, clinical teams rely on high‑performance catheters that combine navigability with soft, atraumatic properties.
Manufacturers in this niche emphasize polymer composites and flexible shafts that maintain responsiveness while minimizing endothelial damage. Though representing a smaller percentage of overall pediatric catheters market share, neurovascular catheters play an outsized role in specialized pediatric care environments where advanced intervention techniques are expanding.
Specialty catheters encompass unique devices used in biopsy, dialysis, hemodialysis, respiratory drainage, and other innovative clinical applications within pediatric care. While this category holds a more modest share compared to traditional catheter types, specialty catheters are increasingly adopted as pediatric care models evolve to support complex and multi‑system treatment protocols.
These devices are engineered with niche clinical use‑cases in mind – for example, dialysis catheters for pediatric renal failure, biopsy catheters for tissue sampling, and surgical drainage catheters for postoperative fluid management. Their share in the pediatric catheters market size is supported by the expanding needs of tertiary pediatric care facilities and integrated multi‑disciplinary clinical teams. Specialty catheters are often adopted where standard catheter solutions are insufficient to address unique procedural demands or where specialized features improve clinical efficiency and patient comfort.
As pediatric medicine continues to incorporate specialized therapeutic approaches, demand for these niche catheter products grows. Healthcare providers increasingly value products that enhance procedure‑specific outcomes and address complications associated with complex disease states. Specialty catheters thus represent a strategic segment within the broader pediatric catheters market Report and highlight nuanced clinical demand beyond core cardiovascular, urology, and IV access categories.
North America Pediatric Catheters Market Share, 2025 (%)
To get more information on the regional analysis of this market, Download Free sample
North America is the largest regional market for pediatric catheters, capturing approximately 34% of global market share due to highly developed healthcare infrastructure, strong hospital networks, and a significant focus on pediatric care. The United States dominates the region, with specialized children’s hospitals, advanced NICUs, and pediatric cardiology centers driving demand for precision catheter devices. The market growth is fueled by adoption of minimally invasive procedures, stringent infection control standards, and the integration of digital technologies for catheter placement and securement. Hospitals prioritize catheters that reduce procedural complications, improve vascular access efficiency, and enhance patient outcomes in neonates and children.
Clinician awareness and continuous training programs also contribute to high utilization of pediatric catheters, including cardiovascular, intravenous, urology, and specialty devices. Technological advancements such as antimicrobial coatings, flexible polymer materials, and image-guided insertion tools are widely implemented to minimize complications and increase procedural success rates. Moreover, federal healthcare policies, reimbursement structures, and hospital investments in pediatric care infrastructure support sustained demand for innovative catheter solutions. The North America pediatric catheters market Report indicates a strong preference for high-quality, clinically validated products, positioning the region as a strategic hub for manufacturers targeting premium pediatric catheter solutions.
Europe accounts for approximately 28% of the global pediatric catheters market, supported by mature healthcare systems, standardized pediatric care protocols, and well-regulated medical device frameworks. Countries such as Germany, the United Kingdom, France, and Italy lead the adoption of pediatric catheters, emphasizing safety, biocompatibility, and procedure efficiency. European hospitals and specialized pediatric care centers prioritize catheter types that minimize infection risk, ensure precise vascular access, and support complex interventional procedures in neonates and children. Regional procurement policies and collaboration among hospitals enhance access to high-performance devices while encouraging cost-effective implementation strategies.
Regulatory compliance and evidence-based clinical guidelines drive the selection of cardiovascular, intravenous, urology, neurovascular, and specialty catheters across pediatric units. The European pediatric catheters market Research Report highlights increasing adoption of advanced catheter materials such as soft silicone and polyurethane, antimicrobial coatings, and tip-tracking technologies to improve clinical outcomes. Expansion of pediatric intensive care units, neonatal cardiac intervention programs, and training initiatives for clinicians also strengthen market uptake. With growing awareness of minimally invasive procedures and pediatric procedural efficiency, Europe remains a strategic region for manufacturers seeking stable demand, premium product adoption, and long-term market growth opportunities within the pediatric catheter segment.
Germany represents a significant portion of the European pediatric catheters market, holding approximately 6% of the regional share. The country’s advanced healthcare infrastructure, extensive neonatal care units, and highly specialized pediatric cardiology programs drive consistent demand for cardiovascular, intravenous, urology, and specialty catheters. German hospitals emphasize early detection of congenital heart defects, comprehensive pediatric interventions, and standardized clinical protocols, making high-quality catheter technologies a clinical priority.
Manufacturers offering precision-engineered, biocompatible devices with antimicrobial coatings and image-guided insertion capabilities are favored in the German market. Hospital procurement strategies focus on evidence-based outcomes, infection prevention, and procedural efficiency, which encourages adoption of premium pediatric catheter products. Furthermore, Germany’s strong emphasis on data-driven device evaluation, procedural training, and integration of minimally invasive technologies ensures that both clinical and operational requirements are met. This combination of infrastructure, clinical expertise, and stringent quality standards positions Germany as a key market for innovative pediatric catheter solutions in Europe.
The United Kingdom accounts for around 4% of Europe’s pediatric catheters market, with demand driven primarily by NHS pediatric care standards and structured children’s hospital systems. The UK market emphasizes adoption of catheter technologies that improve patient safety, reduce infection rates, and support efficient procedural workflows in pediatric ICUs, NICUs, and surgical units. Clinicians prioritize devices with enhanced biocompatibility, atraumatic insertion, and precise placement mechanisms, reflecting a focus on quality outcomes and reduced hospital stays.
Hospitals in the UK increasingly adopt cardiovascular, intravenous, urology, neurovascular, and specialty catheters aligned with evidence-based clinical protocols. Procurement decisions are guided by product reliability, clinical efficacy, and regulatory compliance, ensuring high standards in pediatric interventions. Additionally, ongoing professional training programs and procedural standardization initiatives support effective catheter use across healthcare settings. The UK pediatric catheters market analysis highlights the nation’s strong preference for innovative, safe, and clinically validated catheter solutions, making it a stable and strategic market for manufacturers seeking adoption in mature European healthcare systems.
Asia-Pacific holds roughly 26% of the global pediatric catheters market, driven by rapid expansion of pediatric healthcare infrastructure, increasing procedural volumes, and rising awareness of pediatric medical care. The region encompasses highly developed markets such as Japan and South Korea, alongside fast-growing systems in China, India, and Southeast Asia. Rising government investments in neonatal intensive care units, specialized pediatric hospitals, and advanced surgical facilities create significant demand for pediatric catheter devices across cardiovascular, urology, intravenous, and specialty applications.
Healthcare providers in Asia-Pacific increasingly favor minimally invasive techniques, catheter designs with antimicrobial coatings, flexible polymer materials, and tip-tracking technologies to improve procedural success and reduce complications. The market is further supported by growing clinician training programs, adoption of standardized clinical protocols, and emphasis on patient safety and long-term outcomes. Emerging economies present considerable growth opportunities due to expanding hospital networks, improving access to modern medical devices, and government initiatives promoting pediatric healthcare access. The Asia-Pacific pediatric catheters market outlook suggests that sustained infrastructure development, increasing pediatric care capacity, and rising procedural sophistication will continue to drive market growth across the region.
Japan accounts for approximately 5% of the Asia-Pacific pediatric catheters market, with high demand resulting from advanced pediatric care infrastructure, high survival rates for premature infants, and extensive use of specialized catheter devices in neonatal and pediatric ICUs. Hospitals prioritize precision cardiovascular, intravenous, and specialty catheters designed for small pediatric anatomy, integrating antimicrobial coatings and atraumatic designs to reduce complications.
Japanese healthcare institutions emphasize evidence-based protocols, procedural efficiency, and patient safety, which promotes the adoption of innovative, high-performance pediatric catheters. Clinician training programs, combined with investment in minimally invasive surgical procedures and catheter technologies, further enhance market penetration. With a strong focus on biocompatibility, real-time guidance, and securement technologies, Japan represents a key market for manufacturers offering premium, clinically validated catheter solutions in the Asia-Pacific region.
China holds approximately 8% of the Asia-Pacific pediatric catheters market, driven by rapid expansion of neonatal care infrastructure, increased hospital investments, and government initiatives to improve pediatric healthcare access. Pediatric catheter demand in China spans cardiovascular, intravenous, urology, and specialty applications, with hospitals increasingly adopting advanced products that improve procedural safety, reduce infection risk, and enable precise vascular access.
Rising urban hospital investments, growing clinician expertise, and increased procedural volumes fuel the adoption of flexible, biocompatible, and antimicrobial-coated catheters. Government-driven health programs focused on infant and child healthcare, coupled with expanding NICU and pediatric cardiology facilities, provide long-term growth potential for catheter manufacturers. The China pediatric catheters market analysis indicates a strong preference for innovative, reliable, and clinically validated devices that support improved pediatric outcomes, creating a substantial opportunity for international and domestic medical device companies.
The Rest of World pediatric catheters market, including Latin America, the Middle East, and Africa, accounts for approximately 12% of global market share, driven by gradual expansion of pediatric healthcare infrastructure and public health initiatives. Pediatric catheter adoption is supported by donor-funded neonatal programs, government investments in specialized care facilities, and increased awareness of pediatric vascular and interventional needs.
Hospitals and pediatric units in these regions are increasingly prioritizing catheter products that provide safety, reliability, and procedural efficiency. Demand spans cardiovascular, intravenous, urology, and specialty catheter applications, with manufacturers introducing flexible, biocompatible, and infection-resistant devices suitable for emerging healthcare settings. Training programs for clinicians, standardization of procedural protocols, and partnerships with international medical device suppliers contribute to market growth. Despite infrastructural variability, the Rest of World pediatric catheters market presents a growing opportunity for manufacturers to expand reach, introduce high-performance products, and address unmet pediatric care needs in underserved regions.
Investment in the pediatric catheters market is gaining momentum as healthcare systems globally expand pediatric care and prioritize neonatal and pediatric surgical capabilities. Stakeholders, including private equity, strategic corporate investors, and institutional healthcare funds, are focusing on pediatric catheter innovation portfolios as growth levers within the broader medical devices industry. Enhanced design features that reduce infection rates, improve secure placement, and integrate imaging guidance are drawing capital interest. Emerging market entry strategies present compelling investment opportunities where pediatric healthcare infrastructure is expanding rapidly, such as in Asia‑Pacific and select Middle Eastern regions.
Investment opportunities also lie in partnerships between established catheter manufacturers and emerging biotech firms or startups specializing in next‑generation polymer technologies, antimicrobial surfaces, and procedural analytics. The alignment of hospital procurement priorities with long‑term cost efficiencies – such as reduced procedural complications and length of stay – increases the attractiveness of pediatric catheter innovations. Furthermore, venture capital investments in digital‑assistance technologies that enhance catheter placement and securement have the potential to reshape clinician workflows and establish new growth categories within the pediatric catheters market Forecast.
Innovations in the pediatric catheters market focus on material science, procedural integration, and safety enhancements. Manufacturers are introducing biocompatible polymers that offer high flexibility without sacrificing strength, making them suitable for delicate pediatric vessel navigation. Antimicrobial and antithrombogenic coatings are being integrated to address catheter‑associated bloodstream infection concerns, a major clinical priority in NICUs and pediatric ICUs. These innovations reduce infection incidence and improve overall catheter performance metrics, establishing new standards of care in pediatric device design.
Next‑generation pediatric catheters incorporate real‑time imaging compatibility and guided placement technologies that reduce first‑attempt failure rates and procedural time. Integration with ultrasound and electromagnetic tip tracking enables clinicians to visualize insertions without increased radiation exposure, which is especially important in children. Digital assistance in securement products – including smart locking mechanisms and telemetry for position confirmation – is also emerging, adding value and safety to catheter procedures. As regulatory standards for pediatric medical devices continue to evolve, product development aligns with evidence‑based outcomes, driving adoption of cutting‑edge catheter systems across pediatric care networks.
The pediatric catheters market Report provides a comprehensive scope covering market size estimates at global, regional, and country levels and offers an in‑depth pediatric catheters market Research Report that includes segmentation by product type, application, end user, and geographic distribution. The analysis incorporates the latest Pediatric Catheters industry Report insights on competitive landscapes, sharing profiles of top companies and their market strategies. Detailed Pediatric Catheters industry analysis highlights key trends, opportunities, restraints, and challenges shaping sector developments. The report outlines the adoption patterns of catheter technologies, including cardiovascular, urology, intravenous, neurovascular, and specialty applications, providing stakeholders with actionable insights for strategic planning.
Request for Customization to gain extensive market insights.
Additionally, the pediatric catheters market Forecast component assesses emerging trends in materials, procedural integration technologies, clinician adoption patterns, and healthcare policy influences that drive demand. Regional coverage captures key markets in North America, Europe, Asia‑Pacific, and Rest of World, offering stakeholders a clear understanding of growth dynamics and future opportunities. Investment analysis, new product development insights, and competitive benchmarking enhance the report’s value for decision makers in manufacturing, distribution, and healthcare provider sectors.
Fortune Business Insights says that the global market was valued at USD 9.76 billion in 2025 and is projected to reach USD 21.98 billion by 2034.
The market is expected to grow at a CAGR of 9.45% during the forecast period of 2026–2034.
The Cardiovascular Catheters segment led the market by product, accounting for approximately 42% of the market share, driven by its extensive use in diagnosing and treating congenital heart disorders in children.
Key players include BD (Becton, Dickinson and Company), Coloplast Corp, Getinge, Boston Scientific Corporation, Johnson & Johnson Private Limited, and Medtronic.
Major trends include the adoption of antimicrobial and antithrombotic catheter coatings, image-guided placement technologies, and single-use catheter solutions. North America is a leading regional market, supported by advanced pediatric healthcare infrastructure and strong adoption of minimally invasive procedures.
Get 30-60 hrs Free Customization
Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.
Get In Touch With Us
US +1 833 909 2966 ( Toll Free )
Receive a tailored pricing based on your needs.
Discuss your questions with our industry experts.
Have questions? Get quick answers before you purchase.